Does PANTOPRAZOLE Cause Second primary malignancy? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Second primary malignancy have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.0% of all adverse event reports for PANTOPRAZOLE.
16
Reports of Second primary malignancy with PANTOPRAZOLE
0.0%
of all PANTOPRAZOLE reports
13
Deaths
13
Hospitalizations
How Dangerous Is Second primary malignancy From PANTOPRAZOLE?
Of the 16 reports, 13 (81.3%) resulted in death, 13 (81.3%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE Cause?
Chronic kidney disease (28,127)
Acute kidney injury (15,961)
Renal failure (11,543)
End stage renal disease (8,523)
Renal injury (7,070)
Drug ineffective (5,487)
Off label use (4,279)
Pain (4,057)
Dyspnoea (4,052)
Fatigue (3,797)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which PANTOPRAZOLE Alternatives Have Lower Second primary malignancy Risk?
PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS
PANTOPRAZOLE vs PANTOTHENIC ACID
PANTOPRAZOLE vs PAPAVERINE
PANTOPRAZOLE vs PARACETAMOL
PANTOPRAZOLE vs PARATHYROID HORMONE